FunPep Company Limited Stock

Equities

4881

JP3802640007

Biotechnology & Medical Research

Market Closed - Japan Exchange 02:00:00 2024-04-26 EDT 5-day change 1st Jan Change
146 JPY -1.35% Intraday chart for FunPep Company Limited +2.10% +8.15%

Financials

Sales 2022 1M 6.31K 8.63K Sales 2023 - Capitalization 3.27B 20.66M 28.23M
Net income 2022 -1.17B -7.4M -10.11M Net income 2023 -933M -5.89M -8.05M EV / Sales 2022 1,051 x
Net cash position 2022 2.24B 14.17M 19.37M Net cash position 2023 1.79B 11.32M 15.47M EV / Sales 2023 -
P/E ratio 2022
-2.52 x
P/E ratio 2023
-3.41 x
Employees 15
Yield 2022 *
-
Yield 2023
-
Free-Float 67.34%
More Fundamentals * Assessed data
Dynamic Chart
FunPep Company Limited announced that it has received ¥199.9998 million in funding from Shionogi & Co., Ltd. CI
FunPep Company Limited announced that it expects to receive ¥199.9998 million in funding from Shionogi & Co., Ltd. CI
FunPep Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
FunPep Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
FunPep Company Limited completed the acquisition of Anti-Aging Peptide Co., Ltd. from Hironori Nakagami , Bio Site Start Fund L.P., Naotaka Hashiya, Chiyako Ueda, ReBeage Co., Ltd. and others. CI
FunPep Company Limited agreed to acquire Anti-Aging Peptide Co., Ltd. from Hironori Nakagami , Bio Site Start Fund L.P., Naotaka Hashiya, Chiyako Ueda, ReBeage Co., Ltd. and others. CI
FunPep Company Limited announced that it has received ¥3.741 million in funding from SBI Securities Co., Ltd., Investment Arm CI
FunPep Company Limited announced that it expects to receive ?3.741 million in funding from SBI Securities Co., Ltd., Investment Arm CI
FunPep Company Limited has completed an IPO in the amount of ¥1.780805 billion. CI
FunPep Company Limited has filed an IPO. CI
FunPep Company Limited has withdrawn its IPO. CI
FunPep Company Limited has filed an IPO. CI
FunPep Co., Ltd. announced that it has received ¥460 million in funding from a group of investors CI
FunPep Co., Ltd. announced that it has received ¥100 million in funding from OSAKA University Venture Capital Co., Ltd. CI
Funpep Co., Ltd. announced that it has received funding from Japan Science And Technology Agency and other investors. CI
More news
1 day-1.35%
1 week+2.10%
Current month-16.57%
1 month-14.12%
3 months+2.82%
6 months-5.19%
Current year+8.15%
More quotes
1 week
142.00
Extreme 142
154.00
1 month
141.00
Extreme 141
181.00
Current year
118.00
Extreme 118
325.00
1 year
118.00
Extreme 118
325.00
3 years
118.00
Extreme 118
553.00
5 years
118.00
Extreme 118
843.00
10 years
118.00
Extreme 118
843.00
More quotes
Managers TitleAgeSince
Founder 64 13-10-10
Director of Finance/CFO 51 15-04-30
Chief Tech/Sci/R&D Officer 52 15-06-30
Members of the board TitleAgeSince
Founder 64 13-10-10
Director/Board Member 76 15-02-28
Director/Board Member 60 13-09-30
More insiders
Date Price Change Volume
24-04-26 146 -1.35% 44,300
24-04-25 148 -2.63% 144,400
24-04-24 152 +4.83% 114,300
24-04-23 145 +0.69% 104,900
24-04-22 144 +0.70% 265,700

Delayed Quote Japan Exchange, April 26, 2024 at 02:00 am

More quotes
FunPep Co Ltd is a Japan-based company engaged in the research and development business for pharmaceuticals. The main business is to promote research and development of functional peptides, which are the results of research at the Graduate School of Medicine, Osaka University, and to put them into practical use in the business fields such as pharmaceuticals, cosmetics and medical devices. The business model defines its technical area as a functional peptide-based area and a related area that has synergies with it. The Research & Development pipeline is composed of research themes for antibody-inducing peptides and developed products. The Company is engaged in the sale of peptide active ingredients through cosmetic raw material trading companies or sales companies.
Calendar
More about the company